{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T02:30:55Z","timestamp":1789698655564,"version":"4.0.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.expneurol.2004.08.022","type":"journal-article","created":{"date-parts":[[2004,11,6]],"date-time":"2004-11-06T13:01:09Z","timestamp":1099746069000},"page":"515-524","source":"Crossref","is-referenced-by-count":15,"title":["Alterations in expression of dopamine receptors and neuropeptides in the striatum of GTP cyclohydrolase-deficient mice"],"prefix":"10.1016","volume":"190","author":[{"given":"B.-Y.","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.J.R.","family":"Heales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Canevari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Jenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2004.08.022_bb0005","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0006-8993(93)91069-5","article-title":"Changes in brain dopamine receptors in MPTP parkinsonian monkeys following l-dopa treatment","volume":"625","author":"Alexander","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0010","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/ana.410440411","article-title":"Dopa-responsive dystonia: a clinical and molecular genetic study","volume":"44","author":"Bandmann","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0015","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1073\/pnas.94.7.3363","article-title":"Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa","volume":"94","author":"Bordet","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0020","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF00711370","article-title":"Tetrahydrobiopterin deficiency and brain nitric oxide synthase in the hph1 mouse","volume":"18","author":"Brand","year":"1995","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0025","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1046\/j.1471-4159.1996.66031150.x","article-title":"Neurochemical effects following peripheral administration of tetrahydropterin derivatives to the hph-1 mouse","volume":"66","author":"Brand","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0030","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0006-8993(96)00892-X","article-title":"Impairment of the nitric oxide\/cyclic GMP pathway in cerebellar slices prepared from the hph-1 mouse","volume":"735","author":"Brand","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0035","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0896-6273(91)90374-9","article-title":"Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase","volume":"7","author":"Bredt","year":"1991","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2004.08.022_bb0040","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1046\/j.1471-4159.1999.0732563.x","article-title":"Stimulation of the brain NO\/cyclic GMP pathway by peripheral administration of tetrahydrobiopterin in the hph-1 mouse","volume":"73","author":"Canevari","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0045","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0306-4522(93)90238-B","article-title":"Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum","volume":"54","author":"Chen","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2004.08.022_bb0050","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1210\/endo-128-5-2441","article-title":"Tachykinin (substance-P) gene expression in Leydig cells of the human and mouse testis","volume":"128","author":"Chiwakata","year":"1991","journal-title":"Endocrinology"},{"key":"10.1016\/j.expneurol.2004.08.022_bb0055","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.1523\/JNEUROSCI.17-15-05738.1997","article-title":"Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum","volume":"17","author":"Cragg","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0060","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/syn.890040413","article-title":"Distribution of dopamine D1 and D2 receptors in rabbit cortical areas, hippocampus, and neostriatum in relation to dopamine contents","volume":"4","author":"Dewar","year":"1989","journal-title":"Synapse"},{"key":"10.1016\/j.expneurol.2004.08.022_bb0065","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/brain\/118.6.1473","article-title":"The metabolic topography of idiopathic torsion dystonia","volume":"118","author":"Eidelberg","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2004.08.022_bb0070","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1212\/WNL.53.5.1032","article-title":"Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia","volume":"53","author":"Furukawa","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2004.08.022_bb0075","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0014-2999(90)94802-5","article-title":"Effect of chronic treatment of MPTP monkeys with dopamine D-1 and\/or D-2 receptor agonists","volume":"178","author":"Gagnon","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0080","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.2147780","article-title":"D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons","volume":"250","author":"Gerfen","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2004.08.022_bb0085","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0006-8993(93)90694-I","article-title":"Differential effect of chronic dopaminergic treatment on dopamine D1 and D2 receptors in the monkey brain in MPTP-induced parkinsonism","volume":"602","author":"Graham","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0090","doi-asserted-by":"crossref","first-page":"R509","DOI":"10.1016\/S0960-9822(00)00593-5","article-title":"The basal ganglia","volume":"10","author":"Graybiel","year":"2000","journal-title":"Curr. Biol."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0095","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1073\/pnas.82.2.617","article-title":"Complete coding sequence of rat tyrosine hydroxylase mRNA","volume":"82","author":"Grima","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0100","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1046\/j.1471-4159.1995.65010192.x","article-title":"Biochemistry of somatodendritic dopamine release in substantia nigra: an in vivo comparison with striatal dopamine release","volume":"65","author":"Heeringa","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0105","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0306-4522(95)00120-8","article-title":"Effects of l-DOPA on preproenkephalin and preprotachykinin gene-expression in the MPTP-treated monkey striatum","volume":"68","author":"Herrero","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2004.08.022_bb0110","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1007\/s00415-002-0776-3","article-title":"Normal dopamine transporter binding in dopa responsive dystonia","volume":"249","author":"Huang","year":"2002","journal-title":"J. Neurol."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0115","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0006-8993(95)01309-1","article-title":"Dopamine D3 receptors in the basal ganglia of the common marmoset and following MPTP and l-DOPA treatment","volume":"709","author":"Hurley","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0120","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1046\/j.1471-4159.1996.67020752.x","article-title":"Tetrahydrobiopterin and biogenic amine metabolism in the hph-1 mouse","volume":"67","author":"Hyland","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0125","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/ng1194-236","article-title":"Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene","volume":"8","author":"Ichinose","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0130","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0006-8993(90)90780-F","article-title":"The evolution of nigrostriatal neurochemical changes in the MPTP-treated squirrel monkey","volume":"531","author":"Irwin","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0135","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1523\/JNEUROSCI.05-06-01513.1985","article-title":"Differential visualization of dopamine and norepinephrine uptake sites in rat brain using [3H]mazindol autoradiography","volume":"5","author":"Javitch","year":"1985","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0140","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0169-328X(95)00084-6","article-title":"l-DOPA reverses altered gene-expression of substance-P but not enkephalin in the caudate-putamen of common marmosets treated with MPTP","volume":"32","author":"Jolkkonen","year":"1995","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0145","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/ana.410140309","article-title":"Tetrahydropterin therapy for hyperphenylalaninemia caused by defective synthesis of tetrahydrobiopterin","volume":"14","author":"Kaufman","year":"1983","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0150","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1212\/WNL.50.4.1028","article-title":"Striatal D2 receptors in symptomatic and asymptomatic carriers of dopa-responsive dystonia measured with [11C]-raclopride and positron-emission tomography","volume":"50","author":"Kishore","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2004.08.022_bb0155","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/ana.410440509","article-title":"D2 receptor binding in dopa-responsive dystonia","volume":"44","author":"Kunig","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0160","first-page":"243","article-title":"Brain dopaminergic system studied in patients with dystonia using positron emission tomography","volume":"50","author":"Leenders","year":"1988","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0165","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/mds.870120513","article-title":"Cerebral glucose metabolism in patients with spasmodic torticollis","volume":"12","author":"Magyar-Lehmann","year":"1997","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0170","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/bmj.300.6718.139","article-title":"The dystonias","volume":"300","author":"Marsden","year":"1990","journal-title":"BMJ"},{"key":"10.1016\/j.expneurol.2004.08.022_bb0175","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1471-4159.1988.tb02961.x","article-title":"Biochemical defect of the hph-1 mouse mutant is a deficiency in GTP-cyclohydrolase activity","volume":"50","author":"McDonald","year":"1988","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0180","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0169-328X(97)00123-X","article-title":"Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with l-DOPA therapy","volume":"49","author":"Morissette","year":"1997","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0185","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0306-4522(94)00606-6","article-title":"Preproenkephalin and preprotachykinin messenger-RNA expression in normal human basal ganglia and in Parkinson's disease","volume":"66","author":"Nisbet","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2004.08.022_bb0190","first-page":"377","article-title":"Dopa-responsive dystonia","volume":"50","author":"Nygaard","year":"1988","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0195","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0022-510X(92)90068-V","article-title":"Increased striatal 18F-dopa uptake and normal glucose metabolism in idiopathic dystonia syndrome","volume":"111","author":"Otsuka","year":"1992","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0200","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1212\/WNL.49.5.1432","article-title":"MPTP induces dystonia and parkinsonism. Clues to the pathophysiology of dystonia","volume":"49","author":"Perlmutter","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2004.08.022_bb0205","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0022-510X(88)90106-2","article-title":"D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy","volume":"86","author":"Pierot","year":"1988","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0210","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/ana.410350405","article-title":"Dopa-responsive dystonia: pathological and biochemical observations in a case","volume":"35","author":"Rajput","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0215","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00702-003-0053-3","article-title":"Striatal dopaminergic system in dopa-responsive dystonia: a multi-tracer PET study shows increased D2 receptors","volume":"111","author":"Rinne","year":"2004","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0220","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ana.410300106","article-title":"Dopa-responsive dystonia: [18F]dopa positron emission tomography","volume":"30","author":"Sawle","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0225","doi-asserted-by":"crossref","first-page":"8002","DOI":"10.1523\/JNEUROSCI.22-18-08002.2002","article-title":"Altered dopamine release and uptake kinetics in mice lacking D2 receptors","volume":"22","author":"Schmitz","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0230","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0893-133X(87)90004-2","article-title":"Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases","volume":"1","author":"Seeman","year":"1987","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.expneurol.2004.08.022_bb0235","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1046\/j.1471-4159.1999.0720757.x","article-title":"GTP cyclohydrolase I gene expression in the brains of male and female hph-1 mice","volume":"72","author":"Shimoji","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0240","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/ana.410340518","article-title":"Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism","volume":"34","author":"Snow","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0245","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0306-4522(02)00535-3","article-title":"Alterations in striatal neuropeptid mRNA produced by repeated administration of l-dopa, ropinirole or bromcriptine correlate with dyskinesia induction in MPTP-treated common marmosets","volume":"115","author":"Tel","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2004.08.022_bb0250","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF02740641","article-title":"Mutational and biochemical analysis of dopamine in dystonia: evidence for decreased dopamine D2 receptor inhibition","volume":"16","author":"Todd","year":"1998","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0255","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1212\/WNL.49.3.717","article-title":"In vivo studies on striatal dopamine D1 and D2 site binding in l-dopa-treated Parkinson's disease patients with and without dyskinesias","volume":"49","author":"Turjanski","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2004.08.022_bb0260","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/0306-4522(81)90003-8","article-title":"Dopaminergic dendrites in the pars reticulata of the rat substantia nigra and their striatal input. Combined immunocytochemical localization of tyrosine hydroxylase and anterograde degeneration","volume":"6","author":"Wassef","year":"1981","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2004.08.022_bb0265","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1749-6632.2003.tb07477.x","article-title":"Pathophysiology of Parkinson's disease: the MPTP primate model of the human disorder","volume":"991","author":"Wichmann","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0270","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0306-4522(94)00574-O","article-title":"Chronic l-DOPA treatment differentially regulates gene expression of glutamate decarboxylase, preproenkephalin and preprotachykinin in the striatum of 6-hydroxydopamine-lesioned rat","volume":"66","author":"Zeng","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2004.08.022_bb0275","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1046\/j.1460-9568.2000.00988.x","article-title":"Alterations in preproenkephalin and adenosine-2a receptor mRNA, but not preprotachykinin mRNA correlate with occurrence of dyskinesia in normal monkeys chronically treated with l-DOPA","volume":"12","author":"Zeng","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0280","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s007020170013","article-title":"Chronic high dose l-dopa treatment does not alter the levels of dopamine D-1, D-2 or D-3 receptor in the striatum of normal monkeys: an autoradiographic study","volume":"108","author":"Zeng","year":"2001","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.expneurol.2004.08.022_bb0285","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/347076a0","article-title":"Cloning and expression of human and rat D1 dopamine receptors","volume":"347","author":"Zhou","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2004.08.022_bb0290","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1126\/science.2938259","article-title":"Activation of mouse T-helper cells induces abundant preproenkephalin mRNA synthesis","volume":"232","author":"Zurawski","year":"1986","journal-title":"Science"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488604003437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488604003437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,3]],"date-time":"2019-03-03T03:55:41Z","timestamp":1551585341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488604003437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0014488604003437"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2004.08.022","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}